Hedge Fund - OrbiMed Advisors
Springworks Therapeutics Inc. (SWTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $41,932,326 | 1% | 950,200 | $46.03 |
| 2 | 2024 - Q4 (2024-12-31) | $45,344,270 | 0.93% | 1,255,031 | $34.94 |
| 3 | 2024 - Q3 (2024-09-30) | $44,555,817 | 0.8% | 1,390,631 | $37.36 |
| 4 | 2024 - Q2 (2024-06-30) | $64,315,159 | 1.26% | 1,707,331 | $42.09 |
| 5 | 2024 - Q1 (2024-03-31) | $84,034,832 | 1.53% | 1,707,331 | $46.23 |
| 6 | 2023 - Q4 (2023-12-31) | $117,506,604 | 2.34% | 3,219,359 | $26.10 |
| 7 | 2023 - Q3 (2023-09-30) | $91,753,755 | 1.94% | 3,968,588 | $27.35 |
| 8 | 2023 - Q2 (2023-06-30) | $109,562,577 | 1.98% | 4,178,588 | $26.28 |
| 9 | 2023 - Q1 (2023-03-31) | $115,801,686 | 2.27% | 4,498,900 | $29.23 |
| 10 | 2022 - Q4 (2022-12-31) | $136,552,500 | 2.61% | 5,250,000 | $24.64 |
| 11 | 2022 - Q3 (2022-09-30) | $157,655,000 | 2.92% | 5,525,926 | $28.67 |
| 12 | 2022 - Q2 (2022-06-30) | $148,417,000 | 2.68% | 6,028,307 | $36.57 |
| 13 | 2022 - Q1 (2022-03-31) | $340,238,000 | 5.51% | 6,028,307 | $57.23 |
| 14 | 2021 - Q4 (2021-12-31) | $373,634,000 | 4.8% | 6,028,307 | $66.18 |
| 15 | 2021 - Q3 (2021-09-30) | $382,436,000 | 4.2% | 6,028,307 | $77.06 |
| 16 | 2021 - Q2 (2021-06-30) | $498,108,000 | 5.03% | 6,044,266 | $75.93 |
| 17 | 2021 - Q1 (2021-03-31) | $455,127,000 | 4.25% | 6,186,307 | $78.31 |
| 18 | 2020 - Q4 (2020-12-31) | $537,105,000 | 4.69% | 7,406,307 | $64.37 |
| 19 | 2020 - Q3 (2020-09-30) | $353,059,000 | 4.43% | 7,406,307 | $42.59 |
| 20 | 2020 - Q2 (2020-06-30) | $311,065,000 | 4.37% | 7,406,307 | $35.58 |
| 21 | 2020 - Q1 (2020-03-31) | $199,970,000 | 3.36% | 7,406,307 | $32.60 |
| 22 | 2019 - Q4 (2019-12-31) | $285,069,000 | 4.06% | 7,406,307 | $23.40 |
| 23 | 2019 - Q3 (2019-09-30) | $160,569,000 | 3.04% | 7,406,307 | $23.64 |
The displayed share prices are average quarterly stock market prices.